Dergi makalesi Açık Erişim

Antiangiogenic effect of bevacizumab in monoclonal antibodies in experimental inflammatory pain model

Yaman, Selma; Cukadar, Nursima; Baran, Furkan; Uyanik, Fatih Burak; Kilinc, Metin; Mert, Tufan


DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/67583</identifier>
  <creators>
    <creator>
      <creatorName>Yaman, Selma</creatorName>
      <givenName>Selma</givenName>
      <familyName>Yaman</familyName>
      <affiliation>Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Cukadar, Nursima</creatorName>
      <givenName>Nursima</givenName>
      <familyName>Cukadar</familyName>
      <affiliation>Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Baran, Furkan</creatorName>
      <givenName>Furkan</givenName>
      <familyName>Baran</familyName>
      <affiliation>Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Uyanik, Fatih Burak</creatorName>
      <givenName>Fatih Burak</givenName>
      <familyName>Uyanik</familyName>
      <affiliation>Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Kilinc, Metin</creatorName>
      <givenName>Metin</givenName>
      <familyName>Kilinc</familyName>
      <affiliation>Tibbi Biyokimya Anabilim Dali, Kahramanmaras, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Mert, Tufan</creatorName>
      <givenName>Tufan</givenName>
      <familyName>Mert</familyName>
      <affiliation>Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Antiangiogenic Effect Of Bevacizumab In Monoclonal Antibodies In Experimental Inflammatory Pain Model</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2019</publicationYear>
  <dates>
    <date dateType="Issued">2019-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/67583</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.17826/cumj.532813</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">Purpose: This study aimed to investigate the possible antinociceptive, anti-inflammatory and anti-edema effects of systemic (intaperitoneal) and local (intraplantar) bevacizumab in the experimental inflammation model (introduced with Carrageenan).</description>
  </descriptions>
</resource>
38
12
görüntülenme
indirilme
Görüntülenme 38
İndirme 12
Veri hacmi 2.7 kB
Tekil görüntülenme 31
Tekil indirme 11

Alıntı yap